US FDA Deems Sun Pharma’s Halol Plant Not Compliant with Manufacturing Rules
Sept 9 (Reuters) – Indian drugmaker Sun Pharmaceutical Industries said on Tuesday that the U.S. Food and Drug Administration (FDA) had determined its Halol plant, located in the western state of Gujarat, was not compliant with the regulator’s […]
Indian pharma stocks tumble amid US tariff concerns
With a large portion of pharma revenues coming from US exports, the risk of increased tariffs has led to margin worries and market pullback. Indian pharmaceutical industry is particularly vulnerable […]